These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 33568552)

  • 1. U2AF2 binds IL7R exon 6 ectopically and represses its inclusion.
    Schott G; Galarza-Muñoz G; Trevino N; Chen X; Weirauch M; Gregory SG; Bradrick SS; Garcia-Blanco MA
    RNA; 2021 Feb; 27(5):571-83. PubMed ID: 33568552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antisense modulation of IL7R splicing to control sIL7R expression in human CD4
    Galarza-Muñoz G; Kennedy-Boone D; Schott G; Bradrick SS; Garcia-Blanco MA
    RNA; 2022 Aug; 28(8):1058-1073. PubMed ID: 35613883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cleavage and polyadenylation specificity factor 1 (CPSF1) regulates alternative splicing of interleukin 7 receptor (IL7R) exon 6.
    Evsyukova I; Bradrick SS; Gregory SG; Garcia-Blanco MA
    RNA; 2013 Jan; 19(1):103-15. PubMed ID: 23151878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Epistatic Interaction Controls IL7R Splicing and Increases Multiple Sclerosis Risk.
    Galarza-Muñoz G; Briggs FBS; Evsyukova I; Schott-Lerner G; Kennedy EM; Nyanhete T; Wang L; Bergamaschi L; Widen SG; Tomaras GD; Ko DC; Bradrick SS; Barcellos LF; Gregory SG; Garcia-Blanco MA
    Cell; 2017 Mar; 169(1):72-84.e13. PubMed ID: 28340352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relevance of IL7R genotype and mRNA expression in Dutch patients with multiple sclerosis.
    Sombekke MH; van der Voort LF; Kragt JJ; Nielsen JM; Guzel H; Visser A; Oudejans CB; Crusius JB; Peña AS; Vrenken H; Polman CH; Killestein J
    Mult Scler; 2011 Aug; 17(8):922-30. PubMed ID: 21543551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of interleukin 7 receptor gene polymorphism rs6897932 with multiple sclerosis patients in Khuzestan.
    Majdinasab N; Hosseini Behbahani M; Galehdari H; Mohaghegh M
    Iran J Neurol; 2014 Jul; 13(3):168-71. PubMed ID: 25422737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Context-specific regulation of surface and soluble IL7R expression by an autoimmune risk allele.
    Al-Mossawi H; Yager N; Taylor CA; Lau E; Danielli S; de Wit J; Gilchrist J; Nassiri I; Mahe EA; Lee W; Rizvi L; Makino S; Cheeseman J; Neville M; Knight JC; Bowness P; Fairfax BP
    Nat Commun; 2019 Oct; 10(1):4575. PubMed ID: 31594933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Class II HLA (DRB1, & DQB1) alleles and IL7R (rs6897932) variants and the risk for Multiple Sclerosis in Kerala, India.
    Vinoy N; Sheeja N; Kumar S; Biswas L
    Mult Scler Relat Disord; 2021 May; 50():102848. PubMed ID: 33657520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An intronic polypyrimidine-rich element downstream of the donor site modulates cystic fibrosis transmembrane conductance regulator exon 9 alternative splicing.
    Zuccato E; Buratti E; Stuani C; Baralle FE; Pagani F
    J Biol Chem; 2004 Apr; 279(17):16980-8. PubMed ID: 14966131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skipping of exon 10 in
    Shen L; Lei S; Zhang B; Li S; Huang L; Czachor A; Breitzig M; Gao Y; Huang M; Mo X; Zheng Q; Sun H; Wang F
    Theranostics; 2020; 10(13):5719-5735. PubMed ID: 32483414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigating the exon 6 sequence changes of interleukin 7 receptor A (IL7RA) gene in patients with relapsing-remitting multiple sclerosis.
    Taheri M; Sayad A
    Hum Antibodies; 2018 Feb; 26(2):43-48. PubMed ID: 28582853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A presumed missense variant in the U2AF2 gene causes exon skipping in neurodevelopmental diseases.
    Wang X; You B; Yin F; Chen C; He H; Liu F; Pan Z; Ni X; Pang N; Peng J
    J Hum Genet; 2023 Jun; 68(6):375-382. PubMed ID: 36747105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic risk variants for multiple sclerosis are linked to differences in alternative pre-mRNA splicing.
    Putscher E; Hecker M; Fitzner B; Boxberger N; Schwartz M; Koczan D; Lorenz P; Zettl UK
    Front Immunol; 2022; 13():931831. PubMed ID: 36405756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis.
    Gregory SG; Schmidt S; Seth P; Oksenberg JR; Hart J; Prokop A; Caillier SJ; Ban M; Goris A; Barcellos LF; Lincoln R; McCauley JL; Sawcer SJ; Compston DA; Dubois B; Hauser SL; Garcia-Blanco MA; Pericak-Vance MA; Haines JL;
    Nat Genet; 2007 Sep; 39(9):1083-91. PubMed ID: 17660817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin 7 receptor polymorphisms and the risk of multiple sclerosis: A meta-analysis.
    Tavakolpour S
    Mult Scler Relat Disord; 2016 Jul; 8():66-73. PubMed ID: 27456877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association analysis of IL7R polymorphisms with inflammatory demyelinating diseases.
    Kim JY; Cheong HS; Kim HJ; Kim LH; Namgoong S; Shin HD
    Mol Med Rep; 2014 Feb; 9(2):737-43. PubMed ID: 24337176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An intronic splicing silencer causes skipping of the IIIb exon of fibroblast growth factor receptor 2 through involvement of polypyrimidine tract binding protein.
    Carstens RP; Wagner EJ; Garcia-Blanco MA
    Mol Cell Biol; 2000 Oct; 20(19):7388-400. PubMed ID: 10982855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association Between IL7R Promoter Polymorphisms and Multiple Sclerosis in Turkish Population.
    Simsek H; Geckin H; Sensoz NP; List EO; Arman A
    J Mol Neurosci; 2019 Jan; 67(1):38-47. PubMed ID: 30443838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Association of
    Zhao Z; Xue J; Zhuo Z; Zhong W; Liu H
    Neuropsychiatr Dis Treat; 2022; 18():1855-1859. PubMed ID: 36052273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polypyrimidine tract-binding protein represses splicing of a fibroblast growth factor receptor-2 gene alternative exon through exon sequences.
    Le Guiner C; Plet A; Galiana D; Gesnel MC; Del Gatto-Konczak F; Breathnach R
    J Biol Chem; 2001 Nov; 276(47):43677-87. PubMed ID: 11557769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.